Cubist Systematic Strategies, LLC Cidara Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.64 - $0.92 $39 - $57	62 Added 27.19%	290 $0
Q4 2023 Feb 14, 2024	BUY	$0.68 - $0.97 $94 - $134	139 Added 156.18%	228 $0
Q3 2023 Nov 14, 2023	BUY	$0.77 - $1.16 $68 - $103	89 New	89 $0
Q1 2022 May 16, 2022	SELL	$0.67 - $1.39 $79,086 - $164,075	-118,040 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.18 - $2.18 $139,287 - $257,327	118,040 New	118,040 $150,000
Q2 2018 Aug 14, 2018	SELL	$3.75 - $6.05 $54,375 - $87,725	-14,500 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$4.0 - $8.15 $58,000 - $118,175	14,500 New	14,500 $58,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.43B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.